PubMed:10207023
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-91 | Sentence | denotes | Modulation of E2F complexes during G0 to S phase transition in human primary B-lymphocytes. |
| T2 | 92-173 | Sentence | denotes | The pocket protein-E2F complexes are convergence points for cell cycle signaling. |
| T3 | 174-341 | Sentence | denotes | In the present report, we identified and monitored the pocket protein-E2F complexes in human primary B-lymphocytes after activation by phorbol 12-myristate 13-acetate. |
| T4 | 342-642 | Sentence | denotes | Consistent with previous data from human and mouse fibroblasts and T-lymphocytes, E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B-lymphocyte cell cycle, whereas E2F1 and -3 are first detected in late G1, and their expression levels increase towards S phase. |
| T5 | 643-764 | Sentence | denotes | Intriguingly, the major E2F complex that we detected in quiescent human B-lymphocytes is consisted of pRB, E2F4, and DP1. |
| T6 | 765-919 | Sentence | denotes | Though the levels of DP1 and -2 increase when cells progress from G0 to S, the proportion of DP1 to DP2 remains relatively constant during the cell cycle. |
| T7 | 920-1076 | Sentence | denotes | We also observed an increase in electrophoretic mobility of the predominant E2F components, DP1 and E2F4, as B-lymphocytes progressed from G0 into early G1. |
| T8 | 1077-1260 | Sentence | denotes | This increase in mobility was attributable to dephosphorylation, as lambda phosphatase treatment could convert the slower migrating forms into the corresponding faster mobility forms. |
| T9 | 1261-1379 | Sentence | denotes | We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity. |
| T10 | 1380-1746 | Sentence | denotes | This modulation of DNA binding activity mediated through the dephosphorylation of DP1 and E2F4 could help to explain the lack of in vivo DNA footprinting in late G1 and S phases of gene promoters negatively regulated through E2F sites and suggests a novel mechanism for controlling E2F transcriptional activity during the transition from quiescence to proliferation. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-27 | protein | denotes | E2F complexes |
| T2 | 63-90 | cell_type | denotes | human primary B-lymphocytes |
| T3 | 96-124 | protein | denotes | pocket protein-E2F complexes |
| T4 | 229-257 | protein | denotes | pocket protein-E2F complexes |
| T5 | 261-288 | cell_type | denotes | human primary B-lymphocytes |
| T6 | 377-404 | cell_type | denotes | human and mouse fibroblasts |
| T7 | 409-422 | cell_type | denotes | T-lymphocytes |
| T8 | 424-428 | protein | denotes | E2F4 |
| T9 | 433-436 | protein | denotes | DP1 |
| T10 | 458-474 | protein | denotes | E2F heterodimers |
| T11 | 546-557 | protein | denotes | E2F1 and -3 |
| T12 | 661-678 | protein | denotes | major E2F complex |
| T13 | 699-728 | cell_type | denotes | quiescent human B-lymphocytes |
| T14 | 745-748 | protein | denotes | pRB |
| T15 | 750-754 | protein | denotes | E2F4 |
| T16 | 760-763 | protein | denotes | DP1 |
| T17 | 786-796 | protein | denotes | DP1 and -2 |
| T18 | 858-861 | protein | denotes | DP1 |
| T19 | 865-868 | protein | denotes | DP2 |
| T20 | 996-1010 | protein | denotes | E2F components |
| T21 | 1012-1015 | protein | denotes | DP1 |
| T22 | 1020-1024 | protein | denotes | E2F4 |
| T23 | 1029-1042 | cell_type | denotes | B-lymphocytes |
| T24 | 1192-1214 | protein | denotes | slower migrating forms |
| T25 | 1224-1259 | protein | denotes | corresponding faster mobility forms |
| T26 | 1462-1465 | protein | denotes | DP1 |
| T27 | 1470-1474 | protein | denotes | E2F4 |
| T28 | 1561-1575 | DNA | denotes | gene promoters |
| T29 | 1605-1614 | DNA | denotes | E2F sites |
| T30 | 1662-1665 | protein | denotes | E2F |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-91 | Sentence | denotes | Modulation of E2F complexes during G0 to S phase transition in human primary B-lymphocytes. |
| S2 | 92-173 | Sentence | denotes | The pocket protein-E2F complexes are convergence points for cell cycle signaling. |
| S3 | 174-341 | Sentence | denotes | In the present report, we identified and monitored the pocket protein-E2F complexes in human primary B-lymphocytes after activation by phorbol 12-myristate 13-acetate. |
| S4 | 342-642 | Sentence | denotes | Consistent with previous data from human and mouse fibroblasts and T-lymphocytes, E2F4 and DP1 form the predominant E2F heterodimers both in G0 and G1 phases of the human B-lymphocyte cell cycle, whereas E2F1 and -3 are first detected in late G1, and their expression levels increase towards S phase. |
| S5 | 643-764 | Sentence | denotes | Intriguingly, the major E2F complex that we detected in quiescent human B-lymphocytes is consisted of pRB, E2F4, and DP1. |
| S6 | 765-919 | Sentence | denotes | Though the levels of DP1 and -2 increase when cells progress from G0 to S, the proportion of DP1 to DP2 remains relatively constant during the cell cycle. |
| S7 | 920-1076 | Sentence | denotes | We also observed an increase in electrophoretic mobility of the predominant E2F components, DP1 and E2F4, as B-lymphocytes progressed from G0 into early G1. |
| S8 | 1077-1260 | Sentence | denotes | This increase in mobility was attributable to dephosphorylation, as lambda phosphatase treatment could convert the slower migrating forms into the corresponding faster mobility forms. |
| S9 | 1261-1379 | Sentence | denotes | We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity. |
| S10 | 1380-1746 | Sentence | denotes | This modulation of DNA binding activity mediated through the dephosphorylation of DP1 and E2F4 could help to explain the lack of in vivo DNA footprinting in late G1 and S phases of gene promoters negatively regulated through E2F sites and suggests a novel mechanism for controlling E2F transcriptional activity during the transition from quiescence to proliferation. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 14-27 | NP | denotes | E2F complexes |
| C2 | 63-90 | NP | denotes | human primary B-lymphocytes |
| C3 | 92-124 | NP | denotes | The pocket protein-E2F complexes |
| C4 | 261-288 | NP | denotes | human primary B-lymphocytes |
| C5 | 424-428 | NP | denotes | E2F4 |
| C6 | 433-436 | NP | denotes | DP1 |
| C7 | 546-557 | NP | denotes | E2F1 and -3 |
| C8 | 593-598 | NP | denotes | their |
| C9 | 657-678 | NP | denotes | the major E2F complex |
| C10 | 679-683 | NP | denotes | that |
| C11 | 750-754 | NP | denotes | E2F4 |
| C12 | 760-763 | NP | denotes | DP1 |
| C13 | 858-861 | NP | denotes | DP1 |
| C14 | 980-1010 | NP | denotes | the predominant E2F components |
| C16 | 1012-1015 | NP | denotes | DP1 |
| C17 | 1020-1024 | NP | denotes | E2F4 |
| C15 | 1012-1024 | NP | denotes | DP1 and E2F4 |
| C18 | 1358-1378 | NP | denotes | DNA binding activity |
| C19 | 1399-1419 | NP | denotes | DNA binding activity |
| C21 | 1462-1465 | NP | denotes | DP1 |
| C22 | 1470-1474 | NP | denotes | E2F4 |
| C20 | 1462-1474 | NP | denotes | DP1 and E2F4 |
| R1 | C3 | C1 | coref-ident | The pocket protein-E2F complexes,E2F complexes |
| R2 | C4 | C2 | coref-ident | human primary B-lymphocytes,human primary B-lymphocytes |
| R3 | C8 | C7 | coref-pron | their,E2F1 and -3 |
| R4 | C10 | C9 | coref-relat | that,the major E2F complex |
| R5 | C11 | C5 | coref-ident | E2F4,E2F4 |
| R6 | C12 | C6 | coref-ident | DP1,DP1 |
| R7 | C13 | C12 | coref-ident | DP1,DP1 |
| R8 | C16 | C13 | coref-ident | DP1,DP1 |
| R9 | C17 | C11 | coref-ident | E2F4,E2F4 |
| R10 | C15 | C14 | coref-appos | DP1 and E2F4,the predominant E2F components |
| R11 | C19 | C18 | coref-ident | DNA binding activity,DNA binding activity |
| R12 | C21 | C16 | coref-ident | DP1,DP1 |
| R13 | C22 | C17 | coref-ident | E2F4,E2F4 |
| R14 | C20 | C14 | coref-ident | DP1 and E2F4,the predominant E2F components |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-27 | protein_complex | denotes | E2F complexes |
| T2 | 35-59 | other_name | denotes | G0 to S phase transition |
| T3 | 63-90 | cell_type | denotes | human primary B-lymphocytes |
| T4 | 96-111 | protein_complex | denotes | pocket protein- |
| T5 | 111-124 | protein_complex | denotes | E2F complexes |
| T6 | 152-172 | other_name | denotes | cell cycle signaling |
| T7 | 229-244 | protein_complex | denotes | pocket protein- |
| T8 | 244-257 | protein_complex | denotes | E2F complexes |
| T9 | 261-288 | cell_type | denotes | human primary B-lymphocytes |
| T10 | 309-340 | other_organic_compound | denotes | phorbol 12-myristate 13-acetate |
| T11 | 409-422 | cell_type | denotes | T-lymphocytes |
| T12 | 424-428 | protein_molecule | denotes | E2F4 |
| T13 | 433-436 | protein_molecule | denotes | DP1 |
| T14 | 458-474 | protein_complex | denotes | E2F heterodimers |
| T15 | 507-536 | other_name | denotes | human B-lymphocyte cell cycle |
| T16 | 585-587 | other_name | denotes | G1 |
| T17 | 599-616 | other_name | denotes | expression levels |
| T18 | 634-641 | other_name | denotes | S phase |
| T19 | 661-678 | protein_complex | denotes | major E2F complex |
| T20 | 699-728 | cell_type | denotes | quiescent human B-lymphocytes |
| T21 | 745-748 | protein_molecule | denotes | pRB |
| T22 | 750-754 | protein_molecule | denotes | E2F4 |
| T23 | 760-763 | protein_molecule | denotes | DP1 |
| T24 | 831-833 | other_name | denotes | G0 |
| T25 | 837-838 | other_name | denotes | S |
| T26 | 858-861 | protein_molecule | denotes | DP1 |
| T27 | 865-868 | protein_molecule | denotes | DP2 |
| T28 | 996-1010 | protein_family_or_group | denotes | E2F components |
| T29 | 1012-1015 | protein_molecule | denotes | DP1 |
| T30 | 1020-1024 | protein_molecule | denotes | E2F4 |
| T31 | 1029-1042 | cell_type | denotes | B-lymphocytes |
| T32 | 1059-1061 | other_name | denotes | G0 |
| T33 | 1073-1075 | other_name | denotes | G1 |
| T34 | 1123-1140 | other_name | denotes | dephosphorylation |
| T35 | 1192-1214 | protein_family_or_group | denotes | slower migrating forms |
| T36 | 1224-1259 | protein_family_or_group | denotes | corresponding faster mobility forms |
| T37 | 1305-1327 | other_name | denotes | phosphorylation status |
| T38 | 1399-1419 | other_name | denotes | DNA binding activity |
| T39 | 1441-1458 | other_name | denotes | dephosphorylation |
| T40 | 1462-1465 | protein_molecule | denotes | DP1 |
| T41 | 1470-1474 | protein_molecule | denotes | E2F4 |
| T42 | 1509-1533 | other_name | denotes | in vivo DNA footprinting |
| T43 | 1561-1575 | DNA_family_or_group | denotes | gene promoters |
| T44 | 1605-1614 | DNA_domain_or_region | denotes | E2F sites |
| T45 | 1662-1665 | protein_molecule | denotes | E2F |
| T46 | 1718-1728 | other_name | denotes | quiescence |
| T47 | 1732-1745 | other_name | denotes | proliferation |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T2 | 261-266 | OrganismTaxon | denotes | human | 9606 |
| T3 | 377-382 | OrganismTaxon | denotes | human | 9606 |
| T4 | 387-392 | OrganismTaxon | denotes | mouse | 10088|10090 |
| T6 | 507-512 | OrganismTaxon | denotes | human | 9606 |
| T7 | 709-714 | OrganismTaxon | denotes | human | 9606 |
| T1 | 63-68 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 77-90 | Body_part | denotes | B-lymphocytes | http://purl.obolibrary.org/obo/CL_0000236 |
| T2 | 152-162 | Body_part | denotes | cell cycle | http://purl.obolibrary.org/obo/UBERON_2000098 |
| T3 | 275-288 | Body_part | denotes | B-lymphocytes | http://purl.obolibrary.org/obo/CL_0000236 |
| T4 | 393-404 | Body_part | denotes | fibroblasts | http://purl.obolibrary.org/obo/CL_0000057 |
| T5 | 409-422 | Body_part | denotes | T-lymphocytes | http://purl.obolibrary.org/obo/CL_0000084 |
| T6 | 513-525 | Body_part | denotes | B-lymphocyte | http://purl.obolibrary.org/obo/CL_0000236 |
| T7 | 526-536 | Body_part | denotes | cell cycle | http://purl.obolibrary.org/obo/UBERON_2000098 |
| T8 | 715-728 | Body_part | denotes | B-lymphocytes | http://purl.obolibrary.org/obo/CL_0000236 |
| T9 | 908-918 | Body_part | denotes | cell cycle | http://purl.obolibrary.org/obo/UBERON_2000098 |
| T10 | 1029-1042 | Body_part | denotes | B-lymphocytes | http://purl.obolibrary.org/obo/CL_0000236 |
| T11 | 1145-1151 | Body_part | denotes | lambda | http://purl.obolibrary.org/obo/UBERON_0013424 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 77-90 | Cell | denotes | B-lymphocytes | http://purl.obolibrary.org/obo/CL:0000236 |
| T2 | 275-288 | Cell | denotes | B-lymphocytes | http://purl.obolibrary.org/obo/CL:0000236 |
| T3 | 393-404 | Cell | denotes | fibroblasts | http://purl.obolibrary.org/obo/CL:0000057 |
| T4 | 409-422 | Cell | denotes | T-lymphocytes | http://purl.obolibrary.org/obo/CL:0000084 |
| T5 | 513-525 | Cell | denotes | B-lymphocyte | http://purl.obolibrary.org/obo/CL:0000236 |
| T6 | 515-525 | Cell | denotes | lymphocyte | http://purl.obolibrary.org/obo/CL:0000542 |
| T7 | 715-728 | Cell | denotes | B-lymphocytes | http://purl.obolibrary.org/obo/CL:0000236 |
| T8 | 1029-1042 | Cell | denotes | B-lymphocytes | http://purl.obolibrary.org/obo/CL:0000236 |